Regulations from the Executive in Need of Scrutiny Act of 2019 [S.92]
[Budget and Spending ]
[Consumer Protection ]
[Economic Development ]
[Labor, Jobs, Employment ]
[Small Business ]
[Trade ]
Revises provisions relating to congressional review of agency rulemaking. Specifically, the bill establishes a congressional approval process for a major rule. A major rule may only take effect if Congress approves of the rule. A major rule is a rule that results in (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices for consumers, individual industries, government agencies, or geographic regions; or (3) significant adverse effects on competition, employment, investment, productivity, innovation,
(continued...)
S.92: Regulations from the Executive in Need of Scrutiny Act of 2019
Sponsored by: Sen. Chuck Grassley
Committee On Homeland Security And Governmental Affairs. Reported By Senator Johnson Without Amendment. With Written Report No. 116-311. on 12/14/2020
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 [S.62]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
Allows the Centers for Medicare & Medicaid Services to (1) negotiate drug prices under the Medicare prescription drug benefit, and (2) institute a price structure for the reimbursement of drugs covered under the benefit.
S.62: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019
Sponsored by: Sen. Jack Reed
Read Twice And Referred To The Committee On Finance. on 01/09/2019
Health Savings Act of 2019 [S.12]
[Healthcare ]
[Medicare and Medicaid ]
[Taxes ]
[Insurance ]
[Public Health ]
Modifies the requirements for health savings accounts (HSAs) to rename high deductible health plans as HSA-qualified health plans; allow spouses who have both attained age 55 to make catch-up contributions to the same HSA; make Medicare Part A (hospital insurance benefits) beneficiaries eligible to participate in an HSA; allow individuals eligible for hospital care or medical services under a program of the Indian Health Service or a tribal organization to participate in an HSA; allow members of a health care sharing ministry to participate in an
(continued...)
S.12: Health Savings Act of 2019
Sponsored by: Sen. Marco Rubio
Read Twice And Referred To The Committee On Finance. on 01/03/2019
LIFT (Livable Incomes for Families Today) the Middle Class Act [S.4]
[Taxes ]
[Budget and Spending ]
[Inflation ]
[Funding ]
[Grants ]
[Poverty ]
Establishes a refundable middle class tax credit of up to $3,000 for individuals and up to $6,000 for married individuals filing joint returns. Taxpayers must be at least 18 years of age to receive the credit and may elect to receive payments of the credit in advance on a monthly basis. The bill limits the amount of the credit and eligibility for the credit based on annual income and filing status. Both the income limitations and the amount of the credit must be adjusted for inflation after 2019. The bill also requires the Internal Revenue Service
(continued...)
S.4: LIFT (Livable Incomes for Families Today) the Middle Class Act
Sponsored by: Sen. Kamala D. Harris
Read Twice And Referred To The Committee On Finance. on 01/03/2019
Stop Price Gouging Act [HB-1093]
[Pharmaceuticals ]
[Healthcare ]
[Taxes ]
[Consumer Protection ]
[Medicare and Medicaid ]
[Public Health ]
Imposes an excise tax on pharmaceutical companies that sell prescription drugs that are subject to price spikes that exceed the annual percentage increase in the Chained Consumer Price Index. For each taxable prescription drug, the excise tax ranges from 50% to 100% of price spike revenue received by the company, depending on the size of the price spike and including an adjustment for revenue that is due solely to an increase in the cost of the inputs necessary to manufacture the drug. Pharmaceutical companies must submit specified data regarding
(continued...)
HB-1093: Stop Price Gouging Act
Sponsored by: Rep. Mark Pocan
Introduced In House on 02/07/2019
Protecting America’s Workers Act [HB-1074]
[Labor, Jobs, Employment ]
[Public Safety ]
[Workers' Compensation ]
[Law Enforcement ]
[Mining ]
Expands the coverage of requirements governing workplace safety and health to include protection for federal, state, and local government employees. However, the bill does not cover working conditions otherwise covered by federal requirements for mine safety and health. The bill revises requirements governing worker protection, including by expanding protections for whistle-blowers, such as protections for employees who refuse to perform work because they reasonably believe the work would result in serious injury or illness and for employees who
(continued...)
HB-1074: Protecting America’s Workers Act
Sponsored by: Rep. Raul M. Grijalva
Introduced In House on 02/07/2019
Medicare Negotiation and Competitive Licensing Act of 2019 [HB-1046]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Budget and Spending ]
Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.) The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under
(continued...)
HB-1046: Medicare Negotiation and Competitive Licensing Act of 2019
Sponsored by: Rep. Sean Patrick Maloney
Subcommittee Hearings Held. on 09/25/2019
Phair Pricing Act of 2019 [HB-1034]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
Requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale. Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager. Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors
(continued...)
HB-1034: Phair Pricing Act of 2019
Sponsored by: Rep. Mike Johnson
Referred To The Subcommittee On Health. on 02/07/2019
Humphrey-Hawkins 21st Century Full Employment and Training Act of 2019 Jobs for All Act [HB-1000]
[Labor, Jobs, Employment ]
[Housing ]
[Education ]
[Funding ]
[Grants ]
[Taxes ]
[Budget and Spending ]
[Poverty ]
[Economic Development ]
Creates the National Full Employment Trust Fund to fund employment opportunity grants for the purpose of achieving full employment. The grant program is to be administered by the Department of Labor and funded by a tax on securities transactions and loans from the Federal Reserve System. Labor shall make grants to public and nonprofit entities to create employment opportunities and free-standing job-training programs. Grant funds may be used for, among other things, (1) affordable housing, (2) employment opportunities for disadvantaged youth, (3)
(continued...)
HB-1000: Humphrey-Hawkins 21st Century Full Employment and Training Act of 2019 Jobs for All Act
Sponsored by: Rep. Frederica S. Wilson
Introduced In House on 02/06/2019
Right Rebate Act of 2019 [HB-937]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Consumer Protection ]
Requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
HB-937: Right Rebate Act of 2019
Sponsored by: Sen. Peter Welch
Referred To The Subcommittee On Health. on 01/31/2019
HB-925: North American Wetlands Conservation Extension Act
Sponsored by: Rep. Mike Johnson
Pursuant To The Provisions Of H. Res. 1161, Mrs. Lowey Called Up H.r. 925, With The Senate Amendments Thereto And Moved That The House Agree In The Senate Amendment To The Title Of H.r. 925 And That The House Agree In The Senate Amendment To The Text Of H.r. 925 With An Amendment Consisting Of The Text Of Rules Committee Print 116-66. on 10/01/2020
Social Security 2100 Act [HB-860]
[Social Security ]
[Taxes ]
[Medicare and Medicaid ]
[Senior Citizens ]
[Budget and Spending ]
Increases various Old Age, Survivors, and Disability Insurance (OASDI) benefits and related taxes. The bill increases the primary insurance amount (e.g., the amount a Social Security beneficiary receives if the beneficiary begins receiving benefits at normal retirement age) by increasing the percentage of the beneficiary's average indexed monthly earnings used to calculate the amount. The Bureau of Labor Statistics shall publish a Consumer Price Index for Elderly Consumers, which the Social Security Administration (SSA) shall use to calculate cost-of-living
(continued...)
HB-860: Social Security 2100 Act
Sponsored by: Rep. Sean Patrick Maloney
Introduced In House on 01/30/2019
BRAVE Act of 2019 Burial Rights for America’s Veterans’ Efforts Act of 2019 [HB-497]
[Veterans ]
[Inflation ]
Increases the amounts payable through the Department of Veterans Affairs (VA) for (1) burial and funeral expenses of veterans, and (2) such expenses in connection with a veteran's death due to a service-connected disability. The VA shall also increase such amounts each fiscal year to account for inflation.
HB-497: BRAVE Act of 2019 Burial Rights for America’s Veterans’ Efforts Act of 2019
Sponsored by: Rep. James R. Langevin
Assuming First Sponsorship - Mr. Kinzinger Asked Unanimous Consent That He May Hereafter Be Considered As The First Sponsor Of H.r. 497, A Bill Originally Introduced By Representative Hunter, For The Purpose Of Adding Cosponsors And Requesting Reprintings Pursuant To Clause 7 Of Rule Xii. Agreed To Without Objection. on 02/28/2020
Prescription Drug Price Relief Act of 2019 [HB-465]
[Healthcare ]
[Pharmaceuticals ]
[Medicare and Medicaid ]
[Consumer Protection ]
[Public Health ]
Establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive pricing; HHS must also review prices upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any government-granted exclusivity; (2) issue open, nonexclusive licenses for the drugs; and (3) expedite the review of corresponding applications for generic drugs and biosimilar
(continued...)
HB-465: Prescription Drug Price Relief Act of 2019
Sponsored by: Rep. Barbara Lee
Referred To The Subcommittee On Health. on 01/31/2019
Medicare Drug Price Negotiation Act [HB-448]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Budget and Spending ]
[Consumer Protection ]
[Senior Citizens ]
Makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage (MA) prescription drug plans (PDPs). Under current law, the Centers for Medicare & Medicaid Services (CMS) may neither negotiate the prices of covered drugs nor establish a formulary. The bill repeals these restrictions and instead specifically requires the CMS to (1) negotiate the prices of covered drugs; and (2) either establish a formulary for covered drugs, or require changes to PDP formularies that take
(continued...)
HB-448: Medicare Drug Price Negotiation Act
Sponsored by: Rep. Sean Patrick Maloney
Subcommittee Hearings Held. on 09/25/2019
Youth Vaping Prevention Act of 2019 [HB-293]
[Public Health ]
[Children and Youth ]
[Healthcare ]
[Consumer Protection ]
To prevent and reduce the use of tobacco products, and for other purposes.
HB-293: Youth Vaping Prevention Act of 2019
Sponsored by: Rep. Rosa L. DeLauro
Referred To The Subcommittee On Health. on 03/01/2019
Medicare Prescription Drug Price Negotiation Act of 2019 [HB-275]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
HB-275: Medicare Prescription Drug Price Negotiation Act of 2019
Sponsored by: Rep. Raul M. Grijalva
Subcommittee Hearings Held. on 09/25/2019
HB-224: To amend section 1908 of title 41, United States Code, to exempt certain contracts from the periodic inflation adjustments to an acquisition-related dollar threshold.
Sponsored by: Rep. Nydia M. Velazquez
Introduced In House on 01/03/2019
You have voted HB-224: To amend section 1908 of title 41, United States Code, to exempt certain contracts from the periodic inflation adjustments to an acquisition-related dollar threshold..
Death Tax Repeal Act [HB-218]
[Taxes ]
Repeals the estate and generation-skipping transfer taxes. It also makes conforming amendments related to the gift tax.
HB-218: Death Tax Repeal Act
Sponsored by: Rep. Mike Johnson
Introduced In House on 01/03/2019